{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:11:40Z","timestamp":1779207100101,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-04156-w","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:14:29Z","timestamp":1766150069000},"page":"2423-2427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global perspective on implementing ultra-hypofractionated radiation therapy in breast cancer: a survey-based analysis"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4299-6339","authenticated-orcid":false,"given":"Tinatin","family":"Alaverdashvili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Poortmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"issue":"9804","key":"4156_CR1","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","volume":"378","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"2011","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet. 2011;378(9804):1707\u201316. https:\/\/doi.org\/10.1016\/S0140-6736(11)61629-2.","journal-title":"Lancet"},{"issue":"11","key":"4156_CR2","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","volume":"14","author":"JS Haviland","year":"2013","unstructured":"Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et al. The UK standardisation of breast radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14(11):1086\u201394. https:\/\/doi.org\/10.1016\/S1470-2045(13)70386-3.","journal-title":"Lancet Oncol"},{"issue":"4","key":"4156_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","volume":"9","author":"START Trialists\u2019 Group","year":"2008","unstructured":"START Trialists\u2019 Group. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008;9(4):331\u201341. https:\/\/doi.org\/10.1016\/S1470-2045(08)70077-9.","journal-title":"Lancet Oncol"},{"issue":"9618","key":"4156_CR4","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","volume":"371","author":"START Trialists\u2019 Group","year":"2008","unstructured":"START Trialists\u2019 Group. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371(9618):1098\u2013107. https:\/\/doi.org\/10.1016\/S0140-6736(08)60348-7.","journal-title":"Lancet"},{"issue":"6","key":"4156_CR5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa0906260","volume":"362","author":"TJ Whelan","year":"2010","unstructured":"Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362(6):513\u201320. https:\/\/doi.org\/10.1056\/NEJMoa0906260.","journal-title":"N Engl J Med"},{"issue":"15","key":"4156_CR6","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/jnci\/94.15.1143","volume":"94","author":"T Whelan","year":"2002","unstructured":"Whelan T, MacKenzie R, Julian J, Levine M, Shelley W, Grimard L, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst. 2002;94(15):1143\u201350. https:\/\/doi.org\/10.1093\/jnci\/94.15.1143.","journal-title":"J Natl Cancer Inst"},{"issue":"10237","key":"4156_CR7","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","volume":"395","author":"AM Brunt","year":"2020","unstructured":"Brunt AM, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield DJ, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020;395(10237):1613\u201326. https:\/\/doi.org\/10.1016\/S0140-6736(20)30932-6.","journal-title":"Lancet"},{"key":"4156_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2025.110915","volume":"227","author":"AM Brunt","year":"2025","unstructured":"Brunt AM, Cafferty FH, Wheatley D, Sydenham MA, Kirby AM, Coles CE, et al. Patient-and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: results from the phase III FAST-Forward trial randomised nodal sub-study. Radiother Oncol. 2025;227:110915. https:\/\/doi.org\/10.1016\/j.radonc.2025.110915.","journal-title":"Radiother Oncol"},{"issue":"1","key":"4156_CR9","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S1470-2045(21)00539-8","volume":"23","author":"I Meattini","year":"2022","unstructured":"Meattini I, Becherini C, Boersma L, Kaidar-Person O, Marta GN, Montero A, et al. European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer. Lancet Oncol. 2022;23(1):e21-31. https:\/\/doi.org\/10.1016\/S1470-2045(21)00539-8.","journal-title":"Lancet Oncol"},{"issue":"3","key":"4156_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2022.101165","volume":"8","author":"M Caicedo-Mart\u00ednez","year":"2023","unstructured":"Caicedo-Mart\u00ednez M, Li B, Gonz\u00e1lez-Motta A, Carlson C, Zhu H, Bobadilla I, et al. Targeting education as a barrier to implement hypofractionation: results of a country-wide training program. Adv Radiat Oncol. 2023;8(3):101165. https:\/\/doi.org\/10.1016\/j.adro.2022.101165.","journal-title":"Adv Radiat Oncol"},{"key":"4156_CR11","doi-asserted-by":"publisher","DOI":"10.1200\/GO.22.00127","volume":"9","author":"M Mushonga","year":"2023","unstructured":"Mushonga M, Weiss J, Liu ZA, Nyakabau AM, Mohamad O, Tawk B, et al. Hypofractionation in breast cancer radiotherapy across World Bank income groups: results of an international survey. JCO Glob Oncol. 2023;9:e2200127. https:\/\/doi.org\/10.1200\/GO.22.00127.","journal-title":"JCO Glob Oncol"},{"issue":"2","key":"4156_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2021.100877","volume":"7","author":"KL Corrigan","year":"2022","unstructured":"Corrigan KL, Lei X, Ahmad N, Arzu I, Bloom E, Chun SG, et al. Adoption of ultrahypofractionated radiation therapy in patients with breast cancer. Adv Radiat Oncol. 2022;7(2):100877. https:\/\/doi.org\/10.1016\/j.adro.2021.100877.","journal-title":"Adv Radiat Oncol"},{"key":"4156_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1200\/JGO.19.00261","volume":"6","author":"OC Irabor","year":"2020","unstructured":"Irabor OC, Swanson W, Shaukat F, Wirtz J, Mallum AA, Ngoma T, et al. Can the adoption of hypofractionation guidelines expand global radiotherapy access? An analysis for breast and prostate radiotherapy. JCO Glob Oncol. 2020;6:667\u201378. https:\/\/doi.org\/10.1200\/JGO.19.00261.","journal-title":"JCO Glob Oncol"},{"key":"4156_CR14","doi-asserted-by":"publisher","DOI":"10.1200\/GO.22.00215","volume":"8","author":"RD Kraus","year":"2022","unstructured":"Kraus RD, Weil CR, Abdel-Wahab M. Benefits of adopting hypofractionated radiotherapy as a standard of care in low-and middle-income countries. JCO Glob Oncol. 2022;8:e2200215. https:\/\/doi.org\/10.1200\/GO.22.00215.","journal-title":"JCO Glob Oncol"},{"issue":"2","key":"4156_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/jmrs.273","volume":"65","author":"D Hunter","year":"2018","unstructured":"Hunter D, Mauldon E, Anderson N. Cost\u2010containment in hypofractionated radiation therapy: a literature review. J Med Radiat Sci. 2018;65(2):148\u201357. https:\/\/doi.org\/10.1002\/jmrs.273.","journal-title":"J Med Radiat Sci"},{"issue":"5","key":"4156_CR16","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.clon.2020.12.008","volume":"33","author":"GN Marta","year":"2021","unstructured":"Marta GN, Ramiah D, Kaidar-Person O, Kirby A, Coles C, Jagsi R, et al. The financial impact on reimbursement of moderately hypofractionated postoperative radiation therapy for breast cancer: an international consortium report. Clin Oncol. 2021;33(5):322\u201330. https:\/\/doi.org\/10.1016\/j.clon.2020.12.008.","journal-title":"Clin Oncol"},{"key":"4156_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2024.100764","volume":"46","author":"I Ratosa","year":"2024","unstructured":"Ratosa I, Montero A, Ciervide R, Alvarez B, Garc\u00eda-Aranda M, Valero J, et al. Ultra-hypofractionated one-week locoregional radiotherapy for patients with early breast cancer: acute toxicity results. Clin Transl Radiat Oncol. 2024;46:100764. https:\/\/doi.org\/10.1016\/j.ctro.2024.100764.","journal-title":"Clin Transl Radiat Oncol"},{"key":"4156_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2023.100651","volume":"41","author":"A Montero","year":"2023","unstructured":"Montero A, Ci\u00e9rvide R, Canadillas C, \u00c1lvarez B, Garc\u00eda-Aranda M, Alonso R, et al. Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer. Clin Transl Radiat Oncol. 2023;41:100651. https:\/\/doi.org\/10.1016\/j.ctro.2023.100651.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"3","key":"4156_CR19","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ijrobp.2022.12.028","volume":"116","author":"MC Ward","year":"2023","unstructured":"Ward MC, Recht A, Vicini F, Al-Hilli Z, Asha W, Chadha M, et al. Cost-effectiveness analysis of ultra-hypofractionated whole breast radiation therapy alone versus hormone therapy alone or combined treatment for low-risk ER-positive early stage breast cancer in women aged 65 years and older. Int J Radiat Oncol Biol Phys. 2023;116(3):617\u201326. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.12.028.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"4156_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10549-022-06802-1","volume":"197","author":"D Glynn","year":"2022","unstructured":"Glynn D, Bliss J, Brunt AM, Coles CE, Wheatley D, Haviland JS, et al. Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis. Breast Cancer Res Treat. 2022;197(2):405\u201316. https:\/\/doi.org\/10.1007\/s10549-022-06802-1.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04156-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-04156-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04156-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:32:15Z","timestamp":1779204735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-04156-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["4156"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-04156-w","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted according to ethical standards for research involving human participants. Participation in the anonymous survey was voluntary, and informed consent was obtained from all respondents before completing the survey. Formal institutional ethical approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}